Seres Therapeutics, Inc. (NASDAQ:MCRB) Q3 2025 Earnings Call Transcript
Operator: Good day, everyone, and thank you for standing by. My name is RG, and I will be your conference operator today.
Seres Therapeutics Inc. (MCRB)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Marshall Wace LLP Paul Marshall And Ian Wace | 120,177 | $1,788,234 | -5% | 0% |
| 2. | 683 Capital Partners Ari Zweiman | 52,314 | $778,432 | 0.03% | |
| 3. | 42,830 | $637,310 | +77% | 0% | |
| 4. | Lion Point Didric Cederholm | 31,570 | $469,762 | +17% | 2.43% |
| 5. | Citadel Investment Group Ken Griffin | 31,418 | $467,500 | +2% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.15 | 5,825,495 | $18,350,309.25 | 5,825,495 | 2022-07-05 | Filing | |
| $3.15 | 2,912,748 | $9,175,156.20 | 5,875,711 | 2022-07-05 | Filing | |
| $2.25 | 4,444,444 | $9,999,999.00 | 4,444,444 | 2019-06-18 | Filing | |
| $2.25 | 4,444,444 | $9,999,999.00 | 4,444,444 | 2019-06-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.47 | 259 | $2,193.73 | 11,577 | 2026-02-15 | Filing | |
| $8.47 | 75 | $635.25 | 8,557 | 2026-02-15 | Filing | |
| $8.47 | 78 | $660.66 | 7,789 | 2026-02-15 | Filing | |
| $8.47 | 89 | $753.83 | 7,677 | 2026-02-15 | Filing | |
| $17.30 | 1,042 | $18,026.60 | 8,401 | 2025-11-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,155,850 | $17,236,411 | 5.32% | |
| 2. | 324,214 | $4,824,304 | 0% | |
| 3. | 179,929 | $2,677,344 | 0% | |
| 4. | 151,200 | $2,249,856 | 0% | |
| 5. | 103,621 | $1,541,880 | 0% |
News See All
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q2 2025 Earnings Call Transcript
Operator: Good morning, and welcome to the Seres Therapeutics Second Quarter 2025 Results and Business Update Call. [Operator Instructions] Please note, this call is being recorded.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q1 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Kate, and I will be your conference operator today.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q3 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Bella, and I will be your conference operator today.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q2 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. At this time, I would like to welcome everyone to Seres Therapeutics Second Quarter 2024 Earnings Conference Call.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q1 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Alex, and I will be your conference operator today.
11 Oversold NASDAQ Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold NASDAQ stocks to buy right now.
11 Oversold Healthcare Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold healthcare stocks to buy right now.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, good morning. My name is Abby, and will be your conference operator today.
Hedge Fund Resource Center Billionaire Hedge Funds
